722实时动态胰岛素泵系统对患者长期血糖控制的重要临床价值演示文稿.ppt

及时短期3C可以高效指导糖尿病个体化治疗，是目前治疗糖尿病，进行血糖监测最有效的方法之一，提高患者治疗依从性，增强患者战胜疾病的信心。对于短期内血糖快速升高的2型糖尿病患者，比普通胰岛素治疗方案，3C可以更快，更安全，更精准的血糖控制达标，具有较高性价比。同时在胰岛贝塔细胞功能恢复方面更有利。 * 脆性糖尿病又称不稳定型糖尿病，是 1型糖尿病 中病情最不稳定的类型。其血糖波动范围大 ，不易控制 ，容 易发 生 酮 症 酸 中毒 和低 血糖 两 极 分 化现象，加之患者治疗依从性差 ，进一步影响了血糖控 制。 * * Participants reported personal benefits from wearing a CGM, with 81% saying the CGM helped them recognize hypogly- cemia better, 65% said they had less fear of hypoglycemia, 82% found they were better able to recognize hyperglyce- mia, and 70% reported that their CGM provided them better glycemic control with a lower HbA1c. Of 384 participants who currently wore or had previ- ously worn a CGM, 80% said that they were very or partly satisfied with CGM and 84% said they would recommend a CGM to others. People who were !°very satisfied!± with thei CGM had a significantly lower average HbA1c of 6.9% (195; 52%) compared to 7.2% for those who said they are !°partly satisfied!± to !°very dissatisfied!± with their (183; 48%) (P .01). Among 35 participants who said they were !°very dissatisfied!± with CGM, 31 were no longe wearing a CGM and the other 4 were using older generation CGM systems. * Click on Sample Patient—we are going to use the sample patient to make our changes today. Click on Open Click on Sample Patient—we are going to use the sample patient to make our changes today. Click on Open Click on Sample Patient—we are going to use the sample patient to make our changes today. Click on Open * 3C治疗组与CS Ⅱ治疗组治疗2型糖尿病血糖波动参数的比较 3C治疗在不增加低血糖风险情况下使血糖更快速、更平稳达标 44 例 2 型糖尿病患者随机分成2 组，分别接受动态血糖监测、持续皮下胰岛素输注( CSⅡ) 、CareLink 糖尿病管理软件联合治疗即3C 治疗和CSⅡ治疗，每组22 例。比较两组血糖波动控制的效果。 Med and Pharm J Chin PLA, 2013,25 (9):52-4. 3C治疗较CSII及MDI更好的降低MBG和HbA1c水平 中国药业,2015,24(5);22-24 使用胰岛素强化治疗 的糖尿病患者 119例，根据血糖监测联合胰岛素强化治疗方法将其随机分为3组。采用实时动态血糖监测系统(CGMS)、胰岛素泵持续皮下 输注系8~(CSII)及监护(CareLink软件)联合治疗的 39例为 3c组；采用 CSII强化治疗 ，以用指尖末梢血糖监测的 40例为 CSII组 ；采 用每 天多次胰岛素注射(MDI)强化治疗，应用CGMS监测血糖的40例为MDI组。 CSII，CGMS，CareLink软件联合为最佳的糖尿病治疗方案 及时短期3C可以高效指导糖尿病个体化治疗